Therapeutic agents for the treatment of multiple drug resistance of cancers
US5635515A · kind A · utility
9Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 3, 1995 |
| Grant date | Jun 3, 1997 |
| Priority date | — |
| Expiry date | Mar 3, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cinchonine, dihydrocinchonine or hydroquinidine are used as multidrug resistance inhibiting substance in the treatment of cancerous tumors by the use of cytotoxic agents. Particularly, cinchonine, dihydrocinchonine or hydroquinidine are used in the preparation of pharmaceutical compositions used in the treatment of cancerous tumors developing the phenomenon of multidrug resistance. Application to the treatment of human cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.